Abeywickrema, Movin;
Kelly, Dominic;
Kadambari, Seilesh;
(2023)
Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities.
Reviews in Medical Virology
, Article e2421. 10.1002/rmv.2421.
(In press).
Preview |
Text
Congenital viral infections research gaps Rev Med Virol 2023.pdf - Published Version Download (318kB) | Preview |
Abstract
Congenital CMV, enteroviruses, human parechovirus and herpes simplex virus are all common causes of severe central nervous system (CNS) infection in neonates. The introduction of screening (i.e. newborn hearing screening programme), integration of molecular syndromic testing (i.e. multiplex polymerase chain reaction assays) and increase in sexually transmitted infections (i.e. anogenital herpes) have contributed to increases in each of these infections over the last decade. However, therapeutic options are highly limited in part due to the lack of epidemiological data informing trials. This review will describe our current understanding of the clinical burden and epidemiology of these severe neonatal CNS infections, outline the novel antiviral and vaccines in the pipeline and suggest future research studies which could help develop new therapeutics.
Type: | Article |
---|---|
Title: | Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1002/rmv.2421 |
Publisher version: | https://doi.org/10.1002/rmv.2421 |
Language: | English |
Additional information: | © 2023 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
Keywords: | CMV, antiviral, enterovirus, herpes simplex virus, parechovirus, vaccine |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/10163383 |
Archive Staff Only
View Item |